CCME Global — 360° view

CCME Global, a company in the Biotechnology industry, reported revenue of ₹0.23 crore and a net loss of ₹0.22 crore for the September 2026 quarter.

CCME Global (BSE: CCME) closed at ₹35.19 on 20 Nov 2026, down 78.2% over the past year. Its market capitalisation is ₹159 crore.

Share price
₹35.19 (20 Nov 2026)
Market cap
₹159 Cr (20 Nov 2026)
Revenue
₹0 Cr (September 2026 quarter)
Net profit
₹-0 Cr (September 2026 quarter)
ROCE
-2.92% (FY26)
ROE
-2.92% (FY26)
Book value
₹8.75 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹158.30 / ₹26.41 (20 Nov 2026)
1-year return
-78.2% (to 20 Nov 2026)
Sector
Healthcare
Industry
Biotechnology
Symbol
BSE: CCME

CCME Global Ltd, formerly Genesis IBRC India Ltd and SSK Lifestyles Ltd, is transitioning from a non-operational biotechnology business towards FMCG, commodities, and minerals trading, manufacturing, and import-export activities under new management.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.